Grants and Contributions

About this information

In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.

The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.

Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.

Found six records

$75,000.00

Nov 1, 2024

For-profit organization

Agreement:

MNC Collab - IEVSSP - IAVI Elarex VSV Stability Study POC

Agreement Number:

1023443

Duration: from Nov 1, 2024 to Jul 31, 2025
Description:

As part of Multinational Corporate Collaboration Program, the project “IAVI Elarex VSV Stability Study POC” will focus on proving that the Elarex formulation and process to stabilize a VSV vectored vaccine, is effective when used with IAVI's Marburg virus vaccine.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5

$15,240.00

Aug 1, 2023

For-profit organization

Agreement:

IP Assist: Intellectual Property Strategy Engagement

Agreement Number:

1008404

Duration: from Aug 1, 2023 to Oct 31, 2023
Description:

The project will support development of intellectual property capacity within the firm.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5

$320,000.00

Jun 1, 2023

For-profit organization

Agreement:

Elarex VSV and Adv Viral Vector Vaccines Stabilization

Agreement Number:

1009921

Duration: from Jun 1, 2023 to Aug 31, 2024
Description:

Stabilization of multiple viral vector platforms with PT120-D to produce strong preclinical evidence of impact.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5

$22,500.00

Sep 6, 2022

For-profit organization

Agreement:

IP Assist: Intellectual Property Strategy Engagement

Agreement Number:

996028

Duration: from Sep 6, 2022 to Jan 3, 2023
Description:

The Project will support development of intellectual property capacity within the Firm.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5

$102,000.00

Sep 1, 2022

For-profit organization

Agreement:

Elarex Viral Vectored Exosomal Vaccine Development and Stabilization

Agreement Number:

998641

Duration: from Sep 1, 2022 to Mar 31, 2023
Description:

Optimization of ultra-stable formulation for viral vectored vaccine, compatible with oral dosing

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5

$74,700.00

Sep 1, 2021

For-profit organization

Agreement:

Design and Testing of Assays to Enable Rapid Prototyping

Agreement Number:

975372

Duration: from Sep 1, 2021 to Mar 31, 2022
Description:

Develop a rapid assay platform to support rapid testing and screening of a vast array of formulations to support our goal of increasing the stability of antibody based therapeutics.

Organization: National Research Council Canada
Program Name: Industrial Research Assistance Program – Contributions to Firms
Location: Burlington, Ontario, CA L7L 4X5